Good News: GenSure Respiratory Self-test Products Approved by NMPA.


Recently, the field of respiratory rapid diagnostics has marked a historic milestone in China.

Three self-developed products by GenSure:

· Respiratory Syncytial Virus (RSV) Antigen Test Kit (Latex Method),

· Respiratory Adenovirus(Radv) Antigen Test Kit (Latex Method) ,

· Mycoplasma pneumoniae Antigen Test Kit (Latex Method), 

—have officially received marketing approval from the National Medical Products Administration (NMPA).


GenSure offers the most comprehensive rapid testing solutions for respiratory pathogens.Ushering in a new era of precise prevention and control for respiratory health for all.

· Influenza A/B Virus Antigen Test Kit — China’s first compliant self-test product in this category 

· COVID-19 Antigen Test Kit — Winner of the Second Prize of the Hebei Provincial Government Patent Award and the Second Prize of Hebei Science and Technology Progress Award 

·  Mycoplasma pneumoniae Antigen Test Kit — Highly susceptible and may worsen in children; early screening helps prevent pneumonia 

·  Respiratory Syncytial Virus (RSV) Antigen Test Kit — Protects vulnerable populations such as children and the elderly; early detection helps prevent severe disease 

· Respiratory Adenovirus(Radv) Antigen Test Kit — At-home self-testing for identification of a key respiratory pathogen 

· Strep A Antigen Test Kit — Blocks transmission and helps prevent household spread; first-in-China design featuring single-buffer system, ready-to-use with no A/B solution mixing required, one-step operation with reduced risk of handling errors and improved simplicity 

· Human Metapneumovirus (hMPV) Antigen Test Kit — High incidence in infants and the elderly; early screening helps prevent severe cough and wheezing conditions 

·  Parainfluenza Virus Antigen Test Kit — Associated with laryngitis and wheezing; early detection helps prevent severe illness 

· Respiratory Pathogen Antigen Multiplex Test Kit — “One card, multiple targets” enabling simultaneous screening of multiple respiratory pathogens; supports rapid triage and reduces missed or misdiagnosis. Based on epidemiological needs, up to 26 customizable combinations are available.

 

 

Contact Us
🌐 Website: www.gensbio.com
📧 Email: info@gensbio.com
📞 Tel: +86-10-56370138

Related Documents

Related News